CLINICAL ROLE -
Study Praises Brodalumab in Psoriasis
AstraZeneca and Amgen tracked psoriasis patients taking brodalumab, ustekinumab (Stelara), or placebo, and the results showed brodalumab produced the greatest results in clearing skin.
Read More
Pharmacist Jailed on Drug Charges Battles for Pharmacy License
A pharmacist who pleaded guilty to drug trafficking and money laundering charges in 2012 is trying his hardest to hold onto his pharmacy license, according to the Tampa Bay Times.
Harvoni Delivers High Hepatitis C Cure Rates
Gilead Sciences Inc. has reported positive results from its phase 2 and phase 3 studies on ledipasvir 90 mg/sofosbuvir 400 mg in patients with chronic hepatitis C virus.
Dupilumab Shows Promise in Treating Asthma
In a recent phase 2b study, patients with asthma reported reduced exacerbations and improved lung function after receiving dupilumab, an investigational therapy from Sanofi-Aventis and Regeneron Pharmaceuticals Inc.
Merck's Investigational Hepatitis C Treatment Confirms Proof-of-Concept
A study exploring Merck's experimental hepatitis C virus treatment has provided proof-of-concept for a 6- to 8-week course of triple therapy.
FDA Accepts Amgen's Application for Cholesterol-Lowering Agent
The FDA is taking a look at Amgen's Biologics License Application for evolocumab.
Trulicity Diabetes Treatment Reaches Pharmacies
Treating patients with type 2 diabetes mellitus just got a little easier.